Medicare Enrolled
Dr. Evan Shlofmitz, DO
Interventional Cardiology · Roslyn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shlofmitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shlofmitz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shlofmitz
Dr. Evan Shlofmitz is an interventional cardiology specialist in Roslyn, NY, with 16 years of NPI registration. Based on federal Medicare data, Dr. Shlofmitz performed 1,337 Medicare services across 1,085 unique beneficiaries.
Between the years covered by Open Payments, Dr. Shlofmitz received a total of $724,126 from 41 pharmaceutical and/or device companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shlofmitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 43% volume in NY
$724,126 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,337
Medicare services
Top 43% in NY for interventional cardiology
1,085
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~84 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
220 | $153 | $600 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
153 | $72 | $270 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
148 | $105 | $442 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
144 | $12 | $52 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
129 | $110 | $406 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
79 | $47 | $173 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
76 | $12 | $45 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
54 | $21 | $78 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
43 | $76 | $313 |
| Cardiac catheterization | 35 | $236 | $1,053 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
33 | $12 | $45 |
| New patient office visit, complex (60-74 min) | 33 | $209 | $764 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
31 | $93 | $341 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 31 | $335 | $1,338 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
30 | $160 | $591 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
25 | $553 | $2,159 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $122 | $447 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
16 | $51 | $198 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $144 | $579 |
| Intravascular ultrasound of heart vessel, initial An ultrasound procedure used to evaluate a blood vessel within the heart during a diagnostic or treatment procedure. |
13 | $71 | $260 |
| Right heart catheterization with coronary angiography A procedure to insert a tube into the right side of the heart and coronary arteries to gather diagnostic information, with review by a radiologist. |
11 | $305 | $1,112 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.3% high complexity
3.3% medium
91.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$724,126
Total received (2018-2024)
Avg $103,447/year across 7 years
Top 1% in NY for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
672
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$505,668 (69.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$183,576 (25.4%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$19,579 (2.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,303 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$193,459
2023
$173,473
2022
$182,892
2021
$115,667
2020
$25,082
2019
$24,879
2018
$8,675
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$50,534
Novo Nordisk Inc
$36,744
Lexicon Pharmaceuticals, Inc.
$36,488
ShockWave Medical, Inc
$29,035
Janssen Pharmaceuticals, Inc
$22,567
Acist Medical Systems, Inc.
$4,900
AstraZeneca Pharmaceuticals LP
$4,745
Abbott Laboratories
$3,122
Boston Scientific Corporation
$1,653
Terumo Medical Corporation
$1,362
Philips North America LLC
$831
Gentuity, LLC
$492
Medtronic, Inc.
$359
Esperion Therapeutics, Inc.
$176
HEARTFLOW, INC.
$150
CVRx, Inc.
$140
CARDIVA MEDICAL, INC.
$101
Novartis Pharmaceuticals Corporation
$37
E.R. Squibb & Sons, L.L.C.
$23
Top 3 companies account for 64.0% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$169,953
Janssen Pharmaceuticals, Inc
$150,200
Abbott Laboratories
$130,145
Amgen Inc.
$70,783
ShockWave Medical, Inc
$56,173
Lexicon Pharmaceuticals, Inc.
$36,488
Philips Electronics North America Corporation
$23,524
Medtronic Vascular, Inc.
$19,765
Shockwave Medical, Inc
$16,436
Chiesi USA, Inc.
$10,235
Cardiovascular Systems Inc.
$6,142
AstraZeneca Pharmaceuticals LP
$5,819
Medtronic, Inc.
$5,697
Acist Medical Systems, Inc.
$5,397
Opsens Inc.
$4,000
BOSTON SCIENTIFIC CORPORATION
$3,121
Boston Scientific Corporation
$3,031
Terumo Medical Corporation
$2,433
Philips North America LLC
$831
CORDIS US CORP.
$542
Gentuity, LLC
$492
Neovasc Medical Inc
$428
Esperion Therapeutics, Inc.
$426
Penumbra, Inc.
$366
Boehringer Ingelheim Pharmaceuticals, Inc.
$241
CathWorks, Inc.
$200
HEARTFLOW, INC.
$150
CVRx, Inc.
$140
Inari Medical, Inc.
$122
Arrow International, Inc.
$118
CARDIVA MEDICAL, INC.
$101
Biohaven Pharmaceuticals, Inc.
$88
SpectraWAVE, Inc
$80
Kestra Medical Technology Services, Inc.
$78
BIOTRONIK INC.
$76
Novartis Pharmaceuticals Corporation
$72
E.R. Squibb & Sons, L.L.C.
$68
Cardinal Health 200, LLC
$57
CeloNova BioSciences, Inc.
$49
Impulse Dynamics (USA) Inc.
$38
CSL Behring
$23
Top 3 companies account for 62.2% of all-time payments
Associated products mentioned in payments ›
(5027) Intact Vascular Und · (5091) Amb Mon & Diag Und · (6399) Angio iFR · (6496) FM Other · (6571) Eagle Eye · (6574) Coronary Other · (6575) Coronary Undivided · (6577) Visions 014 · (9520) IGT Devices Undivided · (BQ9) Coronary IVUS · (P88) IGT Devices FM · 3F · ABSOLUTE PRO · ABSORB · AVVIGO Guidance System · AZUR · AZURE XT DR MRI SURESCAN · Absolute Pro vascular stent system · Asahi Fielder coronary guide wire · Assure WCD · Barostim Neo System · CAMZYOS · CARDIOMEMS · COREVALVE EVOLUT R · COROFLOW · CROME DR MRI SURESCAN · Coronary Orbital Atherectomy System · DIAMONDBACK PERIPHERAL · DRAGONFLY OPSTAR · Diamondback Coronary · Dragonfly OCT · ELIQUIS · ENTRESTO · ESPRIT · EluNIR Radaforolimus Eluting Coronary Stent System · FARXIGA · FFRangio · FFRct · FLOWTRIEVER CATHETER · GENERAL THERAPIES · GENERAL STENTS · GENERAL VASCULAR ACCESS · GLIDESHEATH SLENDER · General - Therapies · General - Vascular Access · Gentuity HF-OCT Imaging System · HD-IVUS · HyperVue Imaging System · Indigo System · Inpefa · JARDIANCE · KENGREAL · LEQVIO · METACROSS OTW · MICRA · MYCARELINK · MYNX CONTROL · NEXLETOL · NEXLIZET · NURTEC ODT · OPTICROSS · OPTIS · Optimizer · Optimizer Smart System · Optis Coronary Imaging System · OptoWire · Ozempic · PCI Optimization · PERCLOSE PROGLIDE · PERCLOSE PROSTYLE · Perclose ProGlide suture mediated closure system · PressureWire FFR · R2P MISAGO · ROTAPRO · Repatha · Resolute · Rybelsus · S · SAVVYWIRE · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SUPERA · SYMPLICITY G3 · SYNERGY · SavvyWire · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Telescope · Turnpike Catheter · ULTREON · Vascular Lithotripsy · VenaSeal · Wegovy · XARELTO · XIENCE V · XIENCE XPEDITION · Xience Sierra Coronary Stent System · Xience V coronary stent system
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for interventional cardiology in NY.
Geographic Context
Interventional cardiologists within 10 mi
160
Per 100K population
11.5
County median income
$143,408
Nearest hospital
ST FRANCIS HOSPITAL - THE HEART CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shlofmitz is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 1% of NY peers, with 16 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shlofmitz experienced with office visit, established patient, complex (40-54 min)?
Based on Medicare claims data, Dr. Shlofmitz performed 220 office visit, established patient, complex (40-54 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shlofmitz receive payments from pharmaceutical companies?
Yes. Dr. Shlofmitz received a total of $724,126 from 41 companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shlofmitz's costs compare to other interventional cardiologists in Roslyn?
Dr. Shlofmitz's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shlofmitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologists in Roslyn
Browse interventional cardiologists in Roslyn ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in NY
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in NY
Which NY interventional cardiologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology